Brad Walters, chief medical officer at for the past year, now has “vice president” in his title as well.

Walters received the promotion “in response to the growth and increased complexity of RTI’s work,” RTI said in a statement. He was named chief medical officer in February 2008.

"Part of RTI’s strategy is to increase our work in bringing drugs to market, which has increased our involvement in clinical trials," said RTI Chief Executive Officer Victoria Haynes. "As a result, Brad’s role has expanded significantly. His breadth of knowledge and experience will continue to provide invaluable leadership in support of our strategy."

Having participated in Phase I and II clinical trials projects, he helped create clinical trial design, analysis and interpretation.

Walters received his medical degree from the Harvard medical school and the Massachusetts Institute of Technology. He also earned a PhD in anatomy and embryology at the University of London. At UNC-Chapel Hill, Walters received a Masters in business administration.

As a member of the faculty at UNC-CH’s medical school, Walters helped establish a radiosurgery program and an epilepsy surgery program.